Ozempic vs Wegovy
Ozempic vs Wegovy: both brands hold the same medicine, semaglutide, from the same maker, Novo Nordisk.
Paste this code into your page. It shows the GLP-1 comparison chart with one plain credit link.
Learn
More about this page
Semaglutide acts on the GLP-1 receptor. GLP-1 is a gut hormone that plays a part in blood sugar and in how much a person eats. What differs is the label. Each brand has its own FDA label, and the two labels list different approved uses. Wegovy also comes as a tablet.
Source: Drucker DJ, Cell Metabolism 2018, PMID 29617641.
The two labels side by side
| Label fact | Ozempic | Wegovy |
|---|---|---|
| Medicine (molecule) | semaglutide | semaglutide |
| Type | GLP-1OZEMPIC is a glucagon-like peptide 1 (GLP-1) receptor agonist | GLP-1WEGOVY is a glucagon-like peptide-1 (GLP-1) receptor agonist |
| Maker on the label | Novo Nordisk Pharmaceutical Industries, LP | Novo Nordisk Pharmaceutical Industries, LP |
| Taken as | Injection: pen or prefilled syringe single-patient-use pens ... single-dose prefilled syringe | Injection: pen single-patient-use pen (WEGOVY FlexTouch) Tablet: tablet Take one WEGOVY tablet orally |
| How often, per label | Once weekly Administer OZEMPIC once weekly, on the same day each week | Once weekly (injection) Administer WEGOVY injection once weekly, on the same day each week Once daily (tablet) Take one WEGOVY tablet orally once daily |
| Approved uses, per label |
|
|
| Boxed warning | Yes WARNING: RISK OF THYROID C-CELL TUMORS | Yes WARNING: RISK OF THYROID C-CELL TUMORS |
| Label read | Ozempic label, version 20, effective June 1, 2026 | Wegovy label, version 19, effective June 18, 2026 |
| FDA approval record | NDA209637, first approved December 5, 2017 | NDA215256, first approved June 4, 2021 NDA218316, first approved December 22, 2025 |
All rows are quoted straight from the two labels. Follow a label link to see the DailyMed version we used.
Where the two labels differ
- Approved uses. The Ozempic label is about adults with type 2 diabetes. It lists blood sugar control, a lower risk of major cardiovascular events (cardiovascular death, or a heart attack or stroke that is not fatal), and a kidney use. The Wegovy label lists excess body weight, lower risk of major cardiovascular events in adults with obesity or overweight, and a liver disease called MASH. MASH is listed for the shot only.
- Ages. For the Wegovy shot, the weight use includes children 12 years and older with obesity. The Wegovy tablets and the Ozempic label list adults only.
- Forms. Wegovy also comes as a once daily tablet. Ozempic tablets exist too, but they share a label with Rybelsus, not with the Ozempic shot. See the GLP-1 pill page.
- FDA approval records. Ozempic was first approved in 2017. The Wegovy shot was first approved in 2021, and Wegovy tablets in 2025, as the table shows.
Using semaglutide products together
The Wegovy label has a limitation of use about other semaglutide products. Here it is in the label's own words.
| Wegovy label, section 1, Limitations of Use | Concomitant use of WEGOVY (semaglutide) tablets or WEGOVY (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended. |
|---|
More side by side pages
For the two tirzepatide brands, see Mounjaro vs Zepbound. To put semaglutide next to tirzepatide, see tirzepatide vs semaglutide. Any other pair is in the GLP-1 comparison chart under "Compare two".
Questions
Is Ozempic the same as Wegovy?
Ozempic and Wegovy hold the same medicine, semaglutide, from the same maker. But they are different products with different FDA labels. The labels list different approved uses.
What is the difference between Ozempic and Wegovy?
The labels differ in approved uses, ages and forms. The Ozempic label covers adults with type 2 diabetes. The Wegovy label covers excess body weight and cardiovascular risk in adults with obesity or overweight. It also lists MASH and a weight use for teens 12 and older, for the shot only. Wegovy comes as a shot and a tablet.
Is Ozempic a GLP-1?
Yes, Ozempic is a GLP-1 medicine. The Ozempic label calls it a glucagon-like peptide 1 (GLP-1) receptor agonist.
Sources
4 sources with read dates
- Ozempic label on DailyMed, Novo Nordisk, version 20 of 2026-06-01, read 2026-10-06
- Wegovy label on DailyMed, Novo Nordisk, version 19 of 2026-06-18, read 2026-10-06
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1, Drucker DJ, Cell Metabolism 2018, PMID 29617641, abstract read on PubMed 2026-10-06
- Drugs@FDA application records for NDA 209637, 215256 and 218316, US Food and Drug Administration, via the openFDA drugsfda API, read 2026-10-06